Photo: Cortex-film/Shutterstock
American and German pharmaceutical firms Pfizer and BioNTech announced on Thursday that they will produce Covid-19 vaccines in Brazil in partnership with homegrown laboratory Eurofarma. The Comirnaty vaccine will be manufactured by the Brazilian firm and distributed throughout Latin America.
According to an official statement, the companies’ expectation is that production will start in 2022, manufacturing more than 100 million doses per year. Technical transfer, on-site development, and installation of equipment should start immediately.
Also according to the statement, the RNA production process of the drug substance will be carried out at Pfizer’s facilities in the U.S. Eurofarma has 10 drug factories, three of them in Brazil. The company is also present in 20 Latin American countries. With the agreement, Pfizer and BioNTech will extend the production of their coronavirus vaccine to 20 factories on four continents.
Panama was once a part of Colombia. Its canal, a monumental engineering achievement of its…
The specialization trend among corporate board members It is not only a matter of perception:…
Panama will hold its presidential elections on Sunday, months after huge protests saw thousands descend…
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…